113 related articles for article (PubMed ID: 37186992)
1. A feasible HPTLC method for concurrent quantitation of allopurinol-montelukast co-therapy in plasma and evaluation of their hepatic and renal effects in rats: Analytical, biochemical, and histopathological study.
Hosny NM; Badary DM; Hareedy MS
J Pharm Biomed Anal; 2023 Sep; 233():115439. PubMed ID: 37186992
[TBL] [Abstract][Full Text] [Related]
2. Innovative HPTLC method with fluorescence detection for assessment of febuxostat-montelukast combination and study of their protective effects against gouty arthritis.
Hosny NM; Atia NN; El-Gizawy SM; Badary DM; Hareedy MS
Analyst; 2018 Sep; 143(18):4366-4378. PubMed ID: 30113041
[TBL] [Abstract][Full Text] [Related]
3. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats.
Abdel-Raheem IT; Khedr NF
Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042
[TBL] [Abstract][Full Text] [Related]
4. Effects of allopurinol on ischemia and reperfusion in rabbit livers.
Taha MO; Simões MJ; Noguerol EC; Mendonça FP; Pascoalick HM; Alves RA; Vivian ME; Morales FP; Campos AC; Magalhães KG; Venerando PS; Tersariol IL; Monteiro HP; Oliveira-Júnior IS; Jurkiewicz A; Caricati-Neto A
Transplant Proc; 2009 Apr; 41(3):820-3. PubMed ID: 19376361
[TBL] [Abstract][Full Text] [Related]
5. Changes of gastric lipase activity after ethanol and indomethacin administration: influence of pretreatment with allopurinol, pentoxifylline and L-DOPA.
Sedlakova A; Kohút A; Sarisský M
Physiol Res; 2001; 50(3):299-307. PubMed ID: 11521741
[TBL] [Abstract][Full Text] [Related]
6. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
7. Montelukast protects against renal ischemia/reperfusion injury in rats.
Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
[TBL] [Abstract][Full Text] [Related]
8. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
9. Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats.
Ibrahim MA; Amin EF; Ibrahim SA; Abdelzaher WY; Abdelrahman AM
Eur J Pharmacol; 2014 Feb; 724():204-10. PubMed ID: 24370493
[TBL] [Abstract][Full Text] [Related]
10. Influence of ferulic acid consumption in ameliorating the cadmium-induced liver and renal oxidative damage in rats.
Sanjeev S; Bidanchi RM; Murthy MK; Gurusubramanian G; Roy VK
Environ Sci Pollut Res Int; 2019 Jul; 26(20):20631-20653. PubMed ID: 31104231
[TBL] [Abstract][Full Text] [Related]
11. HPTLC-Densitometric Determination of Cetirizine and Montelukast Analysis in Combined Tablet Dosage Forms.
Haghighi S; Shapouri MR; Amoli-Diva M; Pourghazi K; Afruzi H
Iran J Pharm Res; 2013; 12(2):303-9. PubMed ID: 24250604
[TBL] [Abstract][Full Text] [Related]
12. Hepatic and Renal Impacts of Lesinurad on Experimental Hyperuricemia: Biochemical, Molecular and Pathological Investigations.
Saeed Alghamdi Y
Pak J Biol Sci; 2021 Jan; 24(7):780-789. PubMed ID: 34486297
[TBL] [Abstract][Full Text] [Related]
13. Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study.
Alghamdi YS; Soliman MM; Nassan MA
BMC Pharmacol Toxicol; 2020 Feb; 21(1):10. PubMed ID: 32041665
[TBL] [Abstract][Full Text] [Related]
14. Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury.
Lu P; Liu F; Yao Z; Wang CY; Chen DD; Tian Y; Zhang JH; Wu YH
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):350-5. PubMed ID: 16109514
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of montelukast on smoke-induced lung injury in rats.
Basyigit I; Sahin M; Sahin D; Yildiz F; Boyaci H; Sirvanci S; Ercan F
Multidiscip Respir Med; 2010 Apr; 5(2):92-8. PubMed ID: 22958835
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats.
Beytur A; Köse E; Sarihan ME; Sapmaz HI; Dogan Z; Cetin A; Vardi N; Turkoz Y; Ekinci N
Ren Fail; 2012; 34(3):343-9. PubMed ID: 22260262
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs.
Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC
Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562
[TBL] [Abstract][Full Text] [Related]
18. Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production.
Helmy MM; El-Gowelli HM
Eur J Pharmacol; 2012 May; 683(1-3):294-300. PubMed ID: 22449377
[TBL] [Abstract][Full Text] [Related]
19. The effects of allopurinol in hepatic ischemia and reperfusion: experimental study in rats.
Rhoden E; Pereira-Lima L; Lucas M; Mauri M; Rhoden C; Pereira-Lima JC; Zettler C; Petteffi L; Belló-Klein A
Eur Surg Res; 2000; 32(4):215-22. PubMed ID: 11014922
[TBL] [Abstract][Full Text] [Related]
20. Effects of antioxidant agents against cyclosporine-induced hepatotoxicity.
Akbulut S; Elbe H; Eris C; Dogan Z; Toprak G; Yalcin E; Otan E; Turkoz Y
J Surg Res; 2015 Feb; 193(2):658-66. PubMed ID: 25281288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
